Drug therapy is typically recommended for the initial treatment of patients with atrial fibrillation, but new research suggests there could be a more effective way. 

Long-term anticoagulation can be recommended for AFib patients 90 years old and older, according to new research. 

Catheter ablation was consistently linked to more substantial LVEF improvements than pharmacological therapy.

The analysis, published in the American Journal of Cardiology, included data from more than 741,000 adult patients with aortic stenosis. 

The clearance includes multiple algorithms capable of identifying key findings in a 30-second ECG.

Both supplements are still perfectly safe for patients to take for other reasons, researchers emphasized. 

No procedure-related deaths were reported, and an absolute LVEF improvement of more than 5% was present in nearly 49% of patients. 

These findings are especially important, the authors wrote, because they suggest there may be a new way to personalize patient care. 

The patch harvests energy from each heartbeat, allowing it to operate with no external power source. 

Irreversible electroporation, the authors noted, could help clinicians avoid the drawbacks of thermal ablation